These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32441304)

  • 21. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An EMT-related gene signature for the prognosis of human bladder cancer.
    Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
    J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
    Liu Z; Sun T; Zhang Z; Bi J; Kong C
    Genomics; 2021 Jan; 113(1 Pt 2):896-907. PubMed ID: 33096258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
    Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
    Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
    Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
    Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
    Qu S; Chen Z; Liu B; Liu J; Wang H
    Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y
    Front Immunol; 2021; 12():724541. PubMed ID: 34512654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
    Shi J; Huang D; Zhang G; Zhao F; Yang L
    Medicine (Baltimore); 2020 Dec; 99(51):e23772. PubMed ID: 33371144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a novel liquid-liquid phase separation gene signature for bladder cancer.
    Guo S; Su Q; Yang Z; Mo W
    Sci Rep; 2024 Sep; 14(1):22552. PubMed ID: 39343809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic identification of prognostic indicators in bladder cancer.
    Quan J; Zhang W; Yu C; Bai Y; Cui J; Lv J; Zhang Q
    Biomark Med; 2020 Sep; 14(13):1243-1254. PubMed ID: 32749145
    [No Abstract]   [Full Text] [Related]  

  • 40. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
    Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D
    Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.